Search details
1.
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Lancet
; 402(10409): 1272-1281, 2023 10 07.
Article
in English
| MEDLINE | ID: mdl-37708904
2.
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.
Gastric Cancer
; 21(5): 831-844, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29397460
3.
Systemic therapy for advanced carcinoid tumors: where do we go from here?
J Natl Compr Canc Netw
; 10(6): 785-93, 2012 Jun 01.
Article
in English
| MEDLINE | ID: mdl-22679120
4.
Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the United States.
Pancreas
; 47(2): 173-182, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29206668
5.
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.
Cancer Gene Ther
; 10(5): 341-52, 2003 May.
Article
in English
| MEDLINE | ID: mdl-12719704
6.
Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.
Cancer Invest
; 22(3): 360-7, 2004.
Article
in English
| MEDLINE | ID: mdl-15493356
Results
1 -
6
de 6
1
Next >
>>